3
Announcements
Trials
Browse
Landscape
Status
Unknown
1
Recruiting
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
15
Observational
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Lymphoid
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Breast
1
Conditions
Sarcoma
1
Prostatic Neoplasms
1
Ovarian Neoplasms
1
Lymphoma
1
Lung Neoplasms
1
Kidney Neoplasms
1
Colorectal Neoplasms
1
Breast Neoplasms
1
Interventions
Surveys and Questionnaires
286
Blood Specimen Collection
145
Gene Expression Profiling
96
Interviews as Topic
83
Immunohistochemistry
78
Polymerase Chain Reaction
64
Surgical Procedures, Operative
62
Magnetic Resonance Spectroscopy
59
Microarray Analysis
55
Flow Cytometry
53
Radiotherapy
49
Amplified Fragment Length Polymorphism Analysis
48
Drug Therapy
46
Observation
45
Biopsy
42
Bevacizumab
40
Reverse Transcriptase Polymerase Chain Reaction
39
Data Collection
35
Sorafenib
29
Psychiatric Rehabilitation
29
Nivolumab
28
palbociclib
26
In Situ Hybridization, Fluorescence
26
Rituximab
25
Hepatectomy
25
Therapeutics
24
Neoadjuvant Therapy
24
Docetaxel
24
Colonoscopy
24
Sunitinib
23
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Observational
×
Referral and Consultation
×
Clear all
NCT02821793
2025-07-01
PRIORITY
Institut Bergonié
Completed
346 enrolled
9 charts